Berkeley Lights, Inc. (BLI) Research

Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products. The company provides a unified technology platform, which encompasses proprietary consumables such as OptoSelect chips and specialized reagent kits, sophisticated automation systems, and purpose-built application and workflow software. BLI extends its services to clients across North America, the Asia Pacific region, and Europe. Founded in 2011, its corporate headquarters are located in Emeryville, California.

Market snapshot

Symbol
BLI
Price
$1.20
Day change
-5.88%
Market cap
$86.6M
P/E ratio
-0.84x
52-week range
0.9797-7.4
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aadi Bioscience, Inc. (AADI)
  • Achilles Therapeutics plc (ACHL)
  • HilleVax, Inc. (HLVX)
  • IGM Biosciences, Inc. (IGMS)
  • Insight Molecular Diagnostics Inc. (IMDX)
  • Jade Biosciences, Inc. (JBIO)
  • Jounce Therapeutics, Inc. (JNCE)
  • Miromatrix Medical Inc. (MIRO)

Recent insider activity

  • Kadia Siddhartha — D-Return (645294 shares) on 2023-10-02
  • Chiminski John R — D-Return (71225 shares) on 2023-10-02
  • Chiminski John R — D-Return (41240 shares) on 2023-10-02
  • Silvester Peter — M-Exempt (140000 shares) on 2023-10-02
  • Silvester Peter — D-Return (64596 shares) on 2023-10-02

Open Berkeley Lights, Inc. (BLI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.